Decheng Capital’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
Other funds holding ACET
Decheng Capital's ACET Position: Q4 2023 in Review
Decheng Capital sold out of Adicet Bio (ACET) in Q4 2023, closing a stake of 12,513 shares — an estimated $274K sold.
Decheng Capital first reported a position in ACET in Q1 2022 and held it in 7 quarters. The position peaked at $11.6M in Q1 2022. 76 funds tracked by Wall St. Rank hold ACET as of Q4 2023.
- Decheng Capital reported no remaining Adicet Bio position as of Q4 2023 after selling out during the quarter.
- Decheng Capital sold 12,513 Adicet Bio shares in Q4 2023, an estimated $274K.
- Decheng Capital first reported a position in Adicet Bio in Q1 2022 and held it in 7 quarters.
- Decheng Capital's Adicet Bio position peaked at $11.6M in Q1 2022.
- 76 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2023.
Based on Decheng Capital's 13F filing for Q4 2023, filed 12 Feb 2024.